Resmed INC Form 4 insider transactions

Director Karen Drexler sold 425 shares of ResMed Inc. common stock at a price of $214.92 on April 29, 2024.

Michael J. Rider, Global General Counsel of ResMed Inc., reports the sale of 81 shares of common stock at $180 per share.

Michael J. Rider, Global General Counsel of ResMed Inc., reports selling 200 shares of ResMed Common Stock on March 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.